Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,647.26
(
0.49%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122817
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Doc328 post# 238167

Thursday, 05/27/2021 5:39:29 PM

Thursday, May 27, 2021 5:39:29 PM

Post# of 257302
Re: Zeposia

Getting a good formulary position could be very troublesome due to price. The MS drugs tend to all be about 80-85k/year but UC med's are less and I don't think they can change one price for one indication and a different price for another.

What is the after-rebate (U.S) price range of the other small-molecule drugs for UC? Maybe they are not that different from the ~$50K you cited for the MS drugs.

Thanks for weighing in!

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today